Free Trial

Procter & Gamble Company (The) $PG Shares Sold by Alps Advisors Inc.

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Alps Advisors cut its Procter & Gamble stake by 4.7% in the third quarter, selling 6,683 shares. It retained 136,836 shares, valued at about $19.9 million.
  • Analyst sentiment remains positive overall: 15 analysts rate PG a Buy and 11 a Hold, for a “Moderate Buy” consensus and an average price target of $170.57.
  • P&G beat quarterly earnings and revenue estimates, with earnings per share of $2.00 and revenue of $23.28 billion; quarterly revenue rose 4% year over year. The company also announced a dividend of about $1.09 per share, representing a 2.6% yield.
  • Five stocks we like better than Procter & Gamble.

Alps Advisors Inc. decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 136,836 shares of the company's stock after selling 6,683 shares during the period. Alps Advisors Inc.'s holdings in Procter & Gamble were worth $19,880,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in PG. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $26,000. Montgomery Financial Services LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $28,000. Paladin Partners LLC bought a new stake in Procter & Gamble in the second quarter valued at approximately $29,000. Evergreen Advisors LLC bought a new stake in Procter & Gamble in the first quarter valued at approximately $37,000. Finally, Toews Corp ADV acquired a new stake in Procter & Gamble in the second quarter worth $37,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Analyst Ratings Changes

PG has been the topic of a number of recent analyst reports. BNP Paribas Exane lifted their price target on shares of Procter & Gamble from $177.00 to $189.00 and gave the stock an "outperform" rating in a research report on Friday, October 23rd. JPMorgan Chase & Co. upped their price objective on shares of Procter & Gamble from $162.00 to $180.00 and gave the company an "overweight" rating in a research report on Friday, October 23rd. Argus downgraded Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. Barclays raised their price objective on Procter & Gamble from $152.00 to $165.00 and gave the stock an "equal weight" rating in a research note on Monday, October 26th. Finally, Wells Fargo & Company lifted their target price on Procter & Gamble from $164.00 to $180.00 and gave the stock an "overweight" rating in a report on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $170.57.

Read Our Latest Research Report on PG

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G has raised its dividend for 70 consecutive years. Its quarterly payout is about $1.09 per share, equivalent to a roughly 2.6% yield, supporting the stock’s appeal to income-focused investors. Article: P&G dividend history and yield
  • Positive Sentiment: Recent coverage points to investor interest in consumer-staples stocks as technology shares weaken. P&G may benefit from its defensive profile and dividend reputation. Article: Consumer staples rotation
  • Neutral Sentiment: Zacks Research made mixed earnings-estimate changes: it lowered several forecasts for 2027 and 2028, while modestly raising some later-period estimates. The mixed revisions offer no clear overall change in the longer-term outlook. Procter & Gamble analyst estimates
  • Neutral Sentiment: Management will discuss strategy and P&G’s long-term transformation at an Investor Day webcast on November 19; investors may look for updates on growth and execution. Article: P&G Investor Day webcast
  • Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct stake by roughly 34%. The sale may concern investors, although insider transactions alone do not establish a change in the company’s prospects. Article: CFO share sale

Insider Buying and Selling

In related news, CAO Matthew W. Janzaruk sold 9,479 shares of the business's stock in a transaction on Tuesday, November 3rd. The shares were sold at an average price of $163.00, for a total transaction of $1,545,077.00. Following the transaction, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $207,173. The trade was a 88.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sundar G. Raman sold 38,253 shares of the company's stock in a transaction on Friday, October 30th. The stock was sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the sale, the chief executive officer directly owned 47,745 shares in the company, valued at $7,877,925. This trade represents a 44.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 161,709 shares of company stock worth $26,244,058 in the last quarter. 0.23% of the stock is owned by company insiders.

Procter & Gamble Price Performance

NYSE PG opened at $165.31 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $170.52. The company has a market capitalization of $383.15 billion, a PE ratio of 24.90, a price-to-earnings-growth ratio of 4.07 and a beta of 0.36. The firm's 50 day moving average is $152.01 and its 200-day moving average is $149.43.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The firm's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.99 earnings per share. Equities research analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. Procter & Gamble's dividend payout ratio is currently 65.51%.

About Procter & Gamble

(Free Report)

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines